BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

465 related articles for article (PubMed ID: 9400593)

  • 1. Host range and cytopathogenicity of the highly attenuated MVA strain of vaccinia virus: propagation and generation of recombinant viruses in a nonhuman mammalian cell line.
    Carroll MW; Moss B
    Virology; 1997 Nov; 238(2):198-211. PubMed ID: 9400593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Marker rescue of the host range restriction defects of modified vaccinia virus Ankara.
    Wyatt LS; Carroll MW; Czerny CP; Merchlinsky M; Sisler JR; Moss B
    Virology; 1998 Nov; 251(2):334-42. PubMed ID: 9837798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early gene expression of vaccinia virus strains replicating (Praha) and non-replicating (modified vaccinia virus strain Ankara, MVA) in mammalian cells.
    Nemecková S; Hainz P; Otáhal P; Gabriel P; Sroller V; Kutinová L
    Acta Virol; 2001; 45(4):243-7. PubMed ID: 11885931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional F11L and K1L genes in modified vaccinia virus Ankara restore virus-induced cell motility but not growth in human and murine cells.
    Zwilling J; Sliva K; Schwantes A; Schnierle B; Sutter G
    Virology; 2010 Sep; 404(2):231-9. PubMed ID: 20627347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Highly attenuated modified vaccinia virus Ankara replicates in baby hamster kidney cells, a potential host for virus propagation, but not in various human transformed and primary cells.
    Drexler I; Heller K; Wahren B; Erfle V; Sutter G
    J Gen Virol; 1998 Feb; 79 ( Pt 2)():347-52. PubMed ID: 9472619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Marker gene swapping facilitates recombinant Modified Vaccinia Virus Ankara production by host-range selection.
    Di Lullo G; Soprana E; Panigada M; Palini A; Erfle V; Staib C; Sutter G; Siccardi AG
    J Virol Methods; 2009 Mar; 156(1-2):37-43. PubMed ID: 19038289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Replication of modified vaccinia virus Ankara in primary chicken embryo fibroblasts requires expression of the interferon resistance gene E3L.
    Hornemann S; Harlin O; Staib C; Kisling S; Erfle V; Kaspers B; Häcker G; Sutter G
    J Virol; 2003 Aug; 77(15):8394-407. PubMed ID: 12857909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant swinepox virus expressing beta-galactosidase: investigation of viral host range and gene expression levels in cell culture.
    Bárcena J; Blasco R
    Virology; 1998 Apr; 243(2):396-405. PubMed ID: 9568038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Restriction of vaccinia virus replication in CHO cells occurs at the stage of viral intermediate protein synthesis.
    Ramsey-Ewing A; Moss B
    Virology; 1995 Feb; 206(2):984-93. PubMed ID: 7856109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Viral host-range factor C7 or K1 is essential for modified vaccinia virus Ankara late gene expression in human and murine cells, irrespective of their capacity to inhibit protein kinase R-mediated phosphorylation of eukaryotic translation initiation factor 2alpha.
    Backes S; Sperling KM; Zwilling J; Gasteiger G; Ludwig H; Kremmer E; Schwantes A; Staib C; Sutter G
    J Gen Virol; 2010 Feb; 91(Pt 2):470-82. PubMed ID: 19846675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complementation of a vaccinia virus host-range K1L gene deletion by the nonhomologous CP77 gene.
    Ramsey-Ewing AL; Moss B
    Virology; 1996 Aug; 222(1):75-86. PubMed ID: 8806489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Introduction of the six major genomic deletions of modified vaccinia virus Ankara (MVA) into the parental vaccinia virus is not sufficient to reproduce an MVA-like phenotype in cell culture and in mice.
    Meisinger-Henschel C; Späth M; Lukassen S; Wolferstätter M; Kachelriess H; Baur K; Dirmeier U; Wagner M; Chaplin P; Suter M; Hausmann J
    J Virol; 2010 Oct; 84(19):9907-19. PubMed ID: 20668072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modified vaccinia Ankara strains with identical coding sequences actually represent complex mixtures of viruses that determine the biological properties of each strain.
    Suter M; Meisinger-Henschel C; Tzatzaris M; Hülsemann V; Lukassen S; Wulff NH; Hausmann J; Howley P; Chaplin P
    Vaccine; 2009 Dec; 27(52):7442-50. PubMed ID: 19539582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modified vaccinia virus Ankara multiplies in rat IEC-6 cells and limited production of mature virions occurs in other mammalian cell lines.
    Okeke MI; Nilssen Ø; Traavik T
    J Gen Virol; 2006 Jan; 87(Pt 1):21-27. PubMed ID: 16361414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Replication-deficient vaccinia virus encoding bacteriophage T7 RNA polymerase for transient gene expression in mammalian cells.
    Wyatt LS; Moss B; Rozenblatt S
    Virology; 1995 Jun; 210(1):202-5. PubMed ID: 7793072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonreplicating vaccinia vector efficiently expresses recombinant genes.
    Sutter G; Moss B
    Proc Natl Acad Sci U S A; 1992 Nov; 89(22):10847-51. PubMed ID: 1438287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stable expression of the vaccinia virus K1L gene in rabbit cells complements the host range defect of a vaccinia virus mutant.
    Sutter G; Ramsey-Ewing A; Rosales R; Moss B
    J Virol; 1994 Jul; 68(7):4109-16. PubMed ID: 8207789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-replicating vaccinia vector efficiently expresses bacteriophage T7 RNA polymerase.
    Sutter G; Ohlmann M; Erfle V
    FEBS Lett; 1995 Aug; 371(1):9-12. PubMed ID: 7664891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High level protein expression in mammalian cells using a safe viral vector: modified vaccinia virus Ankara.
    Hebben M; Brants J; Birck C; Samama JP; Wasylyk B; Spehner D; Pradeau K; Domi A; Moss B; Schultz P; Drillien R
    Protein Expr Purif; 2007 Dec; 56(2):269-78. PubMed ID: 17892951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apoptosis induced by a postbinding step of vaccinia virus entry into Chinese hamster ovary cells.
    Ramsey-Ewing A; Moss B
    Virology; 1998 Mar; 242(1):138-49. PubMed ID: 9501038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.